Huakang Biomedical Holdings Company Limited

Huakang Biomedical Holdings Company Limitedverified

8622.HK

Price:

$0.385

Market Cap:

$174.97M

Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2018-12-13

Stock Exchange

HKSE

Ticker

8622.HK

The Enterprise Value as of December 2025 (TTM) for Huakang Biomedical Holdings Company Limited (8622.HK) is 144.67M

According to Huakang Biomedical Holdings Company Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 144.67M. This represents a change of 56.95% compared to the average of 92.18M of the last 4 quarters.

Huakang Biomedical Holdings Company Limited (8622.HK) Historical Enterprise Value (quarterly & annually)

How has 8622.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Huakang Biomedical Holdings Company Limited over the last ten years is 62.98M. The current 144.67M Enterprise Value has changed 22.87% with respect to the historical average. Over the past ten years (40 quarters), 8622.HK's Enterprise Value was at its highest in in the March 2018 quarter at 170.00M. The Enterprise Value was at its lowest in in the December 2020 quarter at -3294360.00.

Quarterly (TTM)
Annual

Average

62.98M

Median

43.46M

Minimum

-3294360.00

Maximum

153.30M

Huakang Biomedical Holdings Company Limited (8622.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Huakang Biomedical Holdings Company Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 223.69%

Maximum Annual Enterprise Value = 153.30M

Minimum Annual Increase = -1507.45%

Minimum Annual Enterprise Value = -3294360.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202440.56M223.69%
202312.53M-63.86%
202234.67M-25.22%
202146.37M-1507.45%
2020-3294360.00-411.61%
20191.06M-98.08%
201855.02M-59.77%
2017136.77M-10.78%
2016153.30M0.33%

Huakang Biomedical Holdings Company Limited (8622.HK) Average Enterprise Value

How has 8622.HK Enterprise Value performed in the past?

The current Enterprise Value of Huakang Biomedical Holdings Company Limited (8622.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

29.25M

5-year avg

26.17M

10-year avg

62.98M

Huakang Biomedical Holdings Company Limited (8622.HK) Enterprise Value vs. Peers

How is 8622.HK’s Enterprise Value compared to its peers?

Huakang Biomedical Holdings Company Limited’s Enterprise Value is less than Shenzhen Neptunus Interlong Bio-technique Company Limited (180.41M), less than Extrawell Pharmaceutical Holdings Limited (257.00M), less than Tianda Pharmaceuticals Limited (273.96M), less than Bamboos Health Care Holdings Limited (223.05M), less than PuraPharm Corporation Limited (505.75M), less than Tycoon Group Holdings Limited (646.59M), less than Good Fellow Healthcare Holdings Limited (215.25M), less than Tai United Holdings Limited (1.55B), greater than Regent Pacific Group Limited (41.03M), less than China Health Group Limited (336.11M),

Build a custom stock screener for Huakang Biomedical Holdings Company Limited (8622.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Huakang Biomedical Holdings Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Huakang Biomedical Holdings Company Limited (8622.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Huakang Biomedical Holdings Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Huakang Biomedical Holdings Company Limited's Enterprise Value?

What is the highest Enterprise Value for Huakang Biomedical Holdings Company Limited (8622.HK)?

What is the 3-year average Enterprise Value for Huakang Biomedical Holdings Company Limited (8622.HK)?

What is the 5-year average Enterprise Value for Huakang Biomedical Holdings Company Limited (8622.HK)?

How does the current Enterprise Value for Huakang Biomedical Holdings Company Limited (8622.HK) compare to its historical average?